Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Rubstein, A."'
Autor:
Alonso, Ricardo, Carnero Contentti, Edgar, Imhoff, Gaston, Lopez, Pablo A., Rubstein, Adrian, Tizio, Santiago
Publikováno v:
In Multiple Sclerosis and Related Disorders May 2019 30:129-135
Publikováno v:
Frontiers in Medical Technology, Vol 3 (2021)
Background: It is important to identify patients with low adherence to recombinant human growth hormone (r-hGH) therapy and initiate actions to improve adherence. The Merck Patient Support Program (PSP) aims to raise the awareness of these patients a
Externí odkaz:
https://doaj.org/article/c972a75a569246358028f65778e67f58
Autor:
Carnero Contentti, E., Soto de Castillo, I., Daccach Marques, V., López, P.A., Antunes Barreira, A., Armas, E., de Aquino Cruz, C., Rubstein, A., Lavigne Moreira, C., Molina, O.M., Soto, A., Tkachuk, V.
Publikováno v:
In Multiple Sclerosis and Related Disorders February 2018 20:109-114
Autor:
Rubstein, A.P., Makarova, E.B., Trakhtenberg, I.Sh., Kudryavtseva, I.P., Bliznets, D.G., Philippov, Yu.I., Shlykov, I.L.
Publikováno v:
In Diamond & Related Materials February 2012 22:128-135
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pablo A. López, Ricardo Alonso, Santiago Tizio, Adrian Rubstein, Edgar Carnero Contentti, Gaston Imhoff
Publikováno v:
Multiple Sclerosis and Related Disorders. 30:129-135
Current multiple sclerosis (MS) therapeutic options have significantly increased treatment algorithm complexity. This urges physicians to take into account multiple factors in the decision-making process and make an even more thorough analysis of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f46b41e8e7cda39a5dbb31d52cad2c
https://doi.org/10.1016/j.msard.2019.01.056
https://doi.org/10.1016/j.msard.2019.01.056
Autor:
Lucas Alessandro, Jorge Correale, Santiago Crema, Adrian Rubstein, Mariano Marrodan, José Tejada Fernández, María C. Ysrraelit
Publikováno v:
Multiple sclerosis and related disorders. 55
Introduction Therapeutic plasma exchange (TPE) is considered a treatment option for steroid-refractory multiple sclerosis (MS) relapses. Our objective was to assess long-term clinical response to TPE in MS steroid-refractory exacerbations. Methods Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6906c7ca574726058737d09d80354b76
https://pubmed.ncbi.nlm.nih.gov/34332460
https://pubmed.ncbi.nlm.nih.gov/34332460
Publikováno v:
Multiple sclerosis and related disorders. 56
With the recent approval of cladribine tablets, siponimod and ozanimod, there has been a renewed interest into the extent to which these current generation disease-modifying therapies (DMTs) are able to cross into the central nervous system (CNS), an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de2db5a1875df588a565352530e72f82
https://pubmed.ncbi.nlm.nih.gov/34547609
https://pubmed.ncbi.nlm.nih.gov/34547609
Autor:
Ricardo Amâncio Malagoni, Ana Paula Moreira De Freitas, Anderson Lima de Menezes, Rubstein Rafael Naves De Andrade, Rubens Gedraite
Publikováno v:
Blucher Chemical Engineering Proceedings.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab2ec29290db5cbcb3ddd7441d14065
https://doi.org/10.5151/cobecic2019-socp45
https://doi.org/10.5151/cobecic2019-socp45